Huaizhong Health Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Huaizhong Health Group generated cash of -$30,571, which is more than the previous year. Cash used in financing activities reached the amount of $30,571 last year.
Cash Flow
| 2013 | 228 | 0 | 24 |
|---|---|---|---|
| 2014 | 5.77K | -24.94K | 1.27K |
| 2015 | -45.54K | -24.94K | 40.11K |
| 2016 | -3.04K | 852 | 40.11K |
| 2017 | -1.13K | 852 | 0 |
| 2018 | -559 | 526 | 0 |
| 2019 | -14.95K | 0 | 14.95K |
| 2020 | 36 | 0 | 31K |
| 2021 | -31.79K | 0 | 31.79K |
| 2022 | -30.57K | 0 | 30.57K |
ADAD Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | -36 | 0 | 33 | 315 | 2.49K | 7.92K | 25.81K | 0 |
Operating activities | ||||||||||
Net income | -29.17K | -30.82K | -36.48K | -126.09K | -6.36K | -1.13K | 866 | -47.78K | 22.72K | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27K | 959 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.89K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.35K | 16.35K | 0 |
Accounts payable | -150 | -963 | 251 | 0 | 0 | 0 | 0 | -16.35K | -16.35K | 0 |
Cash generated by operating activities | -30.57K | -31.79K | 36 | -14.95K | -559 | -1.13K | -3.04K | -45.54K | 5.77K | 228 |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.94K | -24.94K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 526 | 852 | 852 | -24.94K | -24.94K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 31K | 0 | 0 | 0 | 40K | 40K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 30.57K | 31.79K | 31K | 14.95K | 0 | 0 | 40.11K | 40.11K | 1.27K | 24 |
Net Change In Cash | 0 | 0 | 31.03K | 0 | 0 | -282 | -2.17K | -5.43K | -17.89K | 253 |
Cash at end of period | 0 | 0 | 31K | 0 | 33 | 33 | 315 | 2.49K | 7.92K | 253 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |